Detalhe da pesquisa
1.
Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study.
CMAJ
; 195(46): E1565-E1576, 2023 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011930
2.
Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis.
Can Pharm J (Ott)
; 155(6): 326-333, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36386607